Prestige Wealth Management Group LLC Biomarin Pharmaceutical Inc Transaction History
Prestige Wealth Management Group LLC
- $443 Million
- Q1 2024
A detailed history of Prestige Wealth Management Group LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 52 shares of BMRN stock, worth $4,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 116
55.17%
Holding current value
$4,235
Previous $11,000
63.64%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BMRN
# of Institutions
623Shares Held
181MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.52 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.48 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.18 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.14 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$562 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...